In the Media
PE Hub Europe: 'Partners Group plans to ride pharma reshoring wave'
Pascal Noth, Managing Director Private Equity Health & Life, and Jean Ghabache, Member of Management Private Equity Health & Life, spoke with PE Hub Europe about the huge investment potential within the pharmaceutical services sector. The reshoring of production, driven by supply chain vulnerability, and increased outsourcing by large pharma companies are key trends in the space. In May 2023, Partners Group, on behalf of its clients, invested in Sterling Pharma, a contract development and manufacturing organization, that is positioned to benefit from growth in pharma services.